Logo image of RYTM

RHYTHM PHARMACEUTICALS INC (RYTM) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:RYTM - US76243J1051 - Common Stock

102.32 USD
+1.3 (+1.29%)
Last: 1/12/2026, 10:47:03 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033
Revenue
YoY % growth
RYTM revenue by date.RYTM revenue by date.
23.64M
650.48%
77.428M
227.53%
130.126M
68.06%
191.73M
47.34%
299.01M
55.95%
549.27M
83.70%
997.17M
81.54%
1.528B
53.23%
1.973B
29.12%
1.984B
0.56%
2.197B
10.74%
2.615B
19.03%
EBITDA
YoY % growth
RYTM ebitda by date.RYTM ebitda by date.
-177.49M
-5.09%
-182.599M
-2.88%
-263.94M
-44.55%
-195.568M
25.90%
-161.057M
17.65%
10.173M
106.32%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
RYTM ebit by date.RYTM ebit by date.
-179.16M
-5.35%
-184.357M
-2.90%
-265.503M
-44.02%
-201.64M
24.05%
-166.761M
17.30%
40.284M
124.16%
430.59M
968.89%
887.79M
106.18%
1.308B
47.33%
1.411B
7.87%
1.604B
13.68%
1.973B
23.00%
Operating Margin
RYTM operating margin by date.RYTM operating margin by date.
-757.87%-238.10%-204.04%-105.17%-55.77%7.33%43.18%58.10%66.29%71.12%73.01%75.45%
EPS
YoY % growth
RYTM eps by date.RYTM eps by date.
-3.48
-2.05%
-3.20
8.05%
-4.49
-40.31%
-3.27
27.27%
-2.75
15.71%
0.16
105.97%
5.70
3,369.25%
10.02
75.67%
13.86
38.36%
14.75
6.43%
16.55
12.21%
20.71
25.15%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
-0.84
-16.39%
-0.84
-3.33%
-0.76
-1.89%
-0.68
17.03%
-0.61
27.30%
0.18
121.94%
0.34
144.05%
0.67
198.95%
0.87
242.31%
Revenue
Q2Q % growth
56.119M
34.16%
59.388M
81.59%
68.471M
41.17%
79.829M
55.62%
90.041M
60.45%
107.1M
80.34%
122.4M
78.76%
135.66M
69.94%
151.98M
68.79%
EBITDA
Q2Q % growth
-52.211M
-31.54%
-54.211M
-16.28%
-45.791M
-2.82%
-37.61M
27.09%
N/AN/AN/AN/AN/A
EBIT
Q2Q % growth
-55.01M
-33.34%
-54.638M
-16.24%
-50.183M
-10.79%
-43.444M
17.49%
-39.678M
27.87%
N/AN/AN/AN/A

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.82
-12.33%
-0.74-0.08-11.05%
Q2 2025
Q2Q % growth
-0.75
-8.70%
-0.69-0.06-8.85%
Q1 2025
Q2Q % growth
-0.81
65.53%
-0.72-0.09-13.18%
Q4 2024
Q2Q % growth
-0.72
-2.86%
-0.730.010.76%
Q3 2024
Q2Q % growth
-0.73
3.95%
-0.820.0911.07%
Q2 2024
Q2Q % growth
-0.69
15.85%
-0.730.045.17%
Q1 2024
Q2Q % growth
-2.35
-155.43%
-2.21-0.14-6.55%
Q4 2023
Q2Q % growth
-0.70
6.67%
-0.710.011.68%
Q3 2023
Q2Q % growth
-0.76
3.80%
-0.75-0.01-0.77%
Q2 2023
Q2Q % growth
-0.82
7.87%
-0.81-0.01-1.14%
Q1 2023
Q2Q % growth
-0.92
12.38%
-0.920.000.28%
Q4 2022
Q2Q % growth
-0.75
11.76%
-0.830.089.14%
Q3 2022
Q2Q % growth
-0.79
-12.86%
-1.020.2322.60%
Q2 2022
Q2Q % growth
-0.89
-27.14%
-0.970.087.96%
Q1 2022
Q2Q % growth
-1.05
9.48%
-1.03-0.02-1.53%
Q4 2021
Q2Q % growth
-0.85
-7.59%
-0.930.088.71%
Q3 2021
Q2Q % growth
-0.70
9.09%
-0.820.1214.92%
Q2 2021
Q2Q % growth
-0.70
1.41%
-0.700.00-0.50%
Q1 2021
Q2Q % growth
-1.16
-48.72%
0.30-1.46-484.53%
Q4 2020
Q2Q % growth
-0.79 -0.820.033.19%
Q3 2020
Q2Q % growth
-0.77 -0.820.055.64%
Q2 2020
Q2Q % growth
-0.71 -0.850.1416.53%
Q1 2020
Q2Q % growth
-0.78 -0.860.089.13%
RYTM Yearly EPS VS EstimatesRYTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 0 5 10 15 20
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
51.298M
54.28%
51.719M-421K-0.81%
Q2 2025
Q2Q % growth
48.502M
66.80%
44.506M3.996M8.98%
Q1 2025
Q2Q % growth
32.704M
25.94%
41.121M-8.417M-20.47%
Q4 2024
Q2Q % growth
41.83M
72.61%
39.254M2.576M6.56%
Q3 2024
Q2Q % growth
33.251M
47.76%
33.167M84K0.25%
Q2 2024
Q2Q % growth
29.078M
51.28%
29.365M-287K-0.98%
Q1 2024
Q2Q % growth
25.967M
126.41%
27.434M-1.467M-5.35%
Q4 2023
Q2Q % growth
24.234M
175.70%
25.888M-1.654M-6.39%
Q3 2023
Q2Q % growth
22.504M
425.79%
22.622M-118K-0.52%
Q2 2023
Q2Q % growth
19.221M
111.92%
15.329M3.892M25.39%
Q1 2023
Q2Q % growth
11.469M
664.60%
12.361M-892K-7.22%
Q4 2022
Q2Q % growth
8.79M
382.97%
7.169M1.621M22.61%
Q3 2022
Q2Q % growth
4.28M
315.53%
4.857M-577K-11.88%
Q2 2022
Q2Q % growth
9.07M
3,259.26%
2.635M6.435M244.21%
Q1 2022
Q2Q % growth
1.5M
3,650.00%
2.347M-847K-36.09%
Q4 2021
Q2Q % growth
1.82M 1.737M83K4.78%
Q3 2021
Q2Q % growth
1.03M 952.884K77.116K8.09%
Q2 2021
Q2Q % growth
270K 470.424K-200.424K-42.60%
Q1 2021
Q2Q % growth
40K 61.019M-60.979M-99.93%
Q3 2020
Q2Q % growth
339.997K-339.997K-100.00%
RYTM Yearly Revenue VS EstimatesRYTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 500M 1B 1.5B 2B 2.5B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS-3.88% -14.87% -0.92% -6.33%
Revenue-0.44% 0.69% 0% 0.83%